BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        9/8/2023 9:38:26 AM | Browse: 217 | Download: 825
    
    
        
        
    
        | 
                
                    |  | Received |  | 2023-05-06 20:05 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2023-05-06 20:08 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2023-06-13 01:21 | 
    
        | 
                
                    |  | Revised |  | 2023-07-18 16:39 | 
    
        | 
                
                    |  | Second Decision |  | 2023-08-14 02:57 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2023-08-15 09:04 | 
    
        | 
                
                    |  | Articles in Press |  | 2023-08-15 09:04 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  |  | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2023-08-23 06:56 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2023-09-08 09:38 | 
        
        
            
                | ISSN | 2307-8960 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ | 
            
                | Copyright | ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Immunology | 
    
        | Manuscript Type | Case Report | 
    
        | Article Title | Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report | 
    
        | Manuscript Source | Unsolicited Manuscript | 
    
        | All Author List | Ugur Musabak, Tuba Erdoğan, Serdar Ceylaner, Emre Özbek, Nuretdin Suna and Binnaz Handan Özdemir | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number |  | 
    
        | Corresponding Author | Emre Özbek, MD, Doctor, Doctor, Department of Immunology-Allergy, Etlik City Hospital, Halil Sezai Erkut Street No:5 Yenimahalle/Etlik, Ankara 06490, Ankara, Türkiye. emreozbek55@yahoo.com.tr | 
    
        | Key Words | Common variable immunodeficiency; Abatacept; CTLA4 antigen; Case report | 
    
        | Core Tip | In this article, a 25-year-old female patient who applied to our outpatient clinic with the complaints of severe diarrhea and weight loss is presented. As a result of the clinical examination, laboratory tests and histopathological examinations, the patient was diagnosed with common variable immunodeficiency with severe enteropathy. Variants of uncertain significance were detected in 1 cytotoxic T lymphocyte antigen-4 (CTLA4) gene region and 2 lipopolysaccharide-responsive beige-like anchor gene regions in the patient who underwent Whole Exome Sequencing test. Although these polymorphisms have been listed as non-pathogenic in the variant database, their association with some autoimmune diseases had been shown in the literature before. CTLA-4-Ig fusion protein, which had been shown to be effective in these autoimmune diseases, was administered to our patient without delay and a dramatic improvement was achieved in clinical findings. | 
            
                | Publish Date | 2023-09-08 09:38 | 
    
        | Citation | Musabak U, Erdoğan T, Ceylaner S, Özbek E, Suna N, Özdemir BH. Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report. World J Clin Cases 2023; 11(26): 6176-6182 | 
            
                | URL | https://www.wjgnet.com/2307-8960/full/v11/i26/6176.htm | 
            
                | DOI | https://dx.doi.org/10.12998/wjcc.v11.i26.6176 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345